Strategic Financial Concepts LLC Invests $39,000 in Church & Dwight Co., Inc. (NYSE:CHD)

Strategic Financial Concepts LLC acquired a new stake in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 39,162 shares of the company's stock, valued at approximately $39,000.

Several other institutional investors have also recently modified their holdings of CHD. Holocene Advisors LP bought a new position in shares of Church & Dwight during the 3rd quarter valued at about $104,795,000. State Street Corp increased its position in shares of Church & Dwight by 8.0% during the 3rd quarter. State Street Corp now owns 13,116,334 shares of the company's stock valued at $1,373,542,000 after purchasing an additional 969,006 shares during the last quarter. World Investment Advisors LLC purchased a new stake in Church & Dwight during the 3rd quarter valued at about $58,338,000. Barclays PLC boosted its holdings in Church & Dwight by 63.9% during the 3rd quarter. Barclays PLC now owns 1,106,131 shares of the company's stock valued at $115,832,000 after acquiring an additional 431,257 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its holdings in Church & Dwight by 5.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 8,016,345 shares of the company's stock valued at $839,472,000 after acquiring an additional 429,863 shares during the period. 86.60% of the stock is currently owned by institutional investors.

Insider Transactions at Church & Dwight

In related news, EVP Michael Read bought 1,100 shares of the stock in a transaction that occurred on Monday, December 16th. The shares were bought at an average cost of $106.82 per share, for a total transaction of $117,502.00. Following the completion of the transaction, the executive vice president now owns 2,505 shares of the company's stock, valued at approximately $267,584.10. This trade represents a 78.29 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Rick Spann sold 39,520 shares of Church & Dwight stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $112.00, for a total value of $4,426,240.00. Following the transaction, the executive vice president now owns 4,973 shares in the company, valued at $556,976. This trade represents a 88.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 102,422 shares of company stock worth $11,424,351 in the last ninety days. Insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

CHD has been the subject of several analyst reports. Truist Financial increased their target price on Church & Dwight from $110.00 to $115.00 and gave the company a "buy" rating in a report on Monday, February 3rd. TD Cowen increased their target price on Church & Dwight from $114.00 to $117.00 and gave the company a "buy" rating in a report on Monday, November 4th. JPMorgan Chase & Co. increased their target price on Church & Dwight from $99.00 to $107.00 and gave the company an "underweight" rating in a report on Thursday, January 16th. Royal Bank of Canada restated a "sector perform" rating and set a $105.00 target price on shares of Church & Dwight in a report on Monday, February 3rd. Finally, Piper Sandler dropped their target price on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating for the company in a report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Church & Dwight presently has a consensus rating of "Hold" and a consensus price target of $111.53.

Church & Dwight Stock Down 2.2 %

Shares of CHD traded down $2.41 on Friday, reaching $105.12. The stock had a trading volume of 1,723,559 shares, compared to its average volume of 1,640,525. The firm has a market capitalization of $25.75 billion, a price-to-earnings ratio of 44.36, a price-to-earnings-growth ratio of 3.35 and a beta of 0.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. The company has a 50-day simple moving average of $105.48 and a 200-day simple moving average of $104.54. Church & Dwight Co., Inc. has a 12-month low of $96.35 and a 12-month high of $113.50.

Church & Dwight (NYSE:CHD - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, meeting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same quarter last year, the firm posted $0.65 earnings per share. Sell-side analysts predict that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Friday, February 14th will be paid a $0.295 dividend. This is an increase from Church & Dwight's previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date of this dividend is Friday, February 14th. Church & Dwight's dividend payout ratio (DPR) is 47.68%.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.